Literature DB >> 10863944

Lysosomal transport disorders.

G M Mancini1, A C Havelaar, F W Verheijen.   

Abstract

In the group of lysosomal storage diseases, transport disorders occupy a special place because they represent rare examples of inborn errors of metabolism caused by a defect of an intracellular membrane transporter. In particular, two disorders are caused by a proven defect in carrier-mediated transport of metabolites: cystinosis and the group of sialic acid storage disorders (SASD). The recent identification of the gene mutations for both disorders will improve patient diagnosis and shed light on new physiological mechanisms of intracellular trafficking.

Entities:  

Mesh:

Year:  2000        PMID: 10863944     DOI: 10.1023/a:1005640214408

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  83 in total

Review 1.  The role of vesicular transport proteins in synaptic transmission and neural degeneration.

Authors:  Y Liu; R H Edwards
Journal:  Annu Rev Neurosci       Date:  1997       Impact factor: 12.449

2.  Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay.

Authors:  L Forestier; G Jean; M Attard; S Cherqui; C Lewis; W van't Hoff; M Broyer; M Town; C Antignac
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

3.  Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS).

Authors:  Y Anikster; C Lucero; J W Touchman; M Huizing; G McDowell; V Shotelersuk; E D Green; W A Gahl
Journal:  Mol Genet Metab       Date:  1999-02       Impact factor: 4.797

4.  Sialic acid storage disease with sialuria: clinical and biochemical features in the severe infantile type.

Authors:  R E Stevenson; M Lubinsky; H A Taylor; D A Wenger; R J Schroer; P M Olmstead
Journal:  Pediatrics       Date:  1983-10       Impact factor: 7.124

5.  Nucleotide-activated chloride channels in lysosomal membranes.

Authors:  B C Tilly; G M Mancini; J Bijman; P G van Gageldonk; C E Beerens; R J Bridges; H R de Jonge; F W Verheijen
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

6.  Action of BTN1, the yeast orthologue of the gene mutated in Batten disease.

Authors:  D A Pearce; T Ferea; S A Nosel; B Das; F Sherman
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

7.  Detection and characterization of a transport system mediating cysteamine entry into human fibroblast lysosomes. Specificity for aminoethylthiol and aminoethylsulfide derivatives.

Authors:  R L Pisoni; G Y Park; V Q Velilla; J G Thoene
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

8.  Salla disease variant in a Dutch patient. Potential value of polymorphonuclear leucocytes for heterozygote detection.

Authors:  G M Mancini; P Hu; F W Verheijen; O P van Diggelen; H C Janse; W J Kleijer; F A Beemer; F G Jennekens
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

9.  Mediated calcium transport by isolated human fibroblast lysosomes.

Authors:  R M Lemons; J G Thoene
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

10.  A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal proteolysis.

Authors:  R L Pisoni; T L Acker; K M Lisowski; R M Lemons; J G Thoene
Journal:  J Cell Biol       Date:  1990-02       Impact factor: 10.539

View more
  13 in total

1.  Identification and characterization of a lysosomal transporter for small neutral amino acids.

Authors:  C Sagné; C Agulhon; P Ravassard; M Darmon; M Hamon; S El Mestikawy; B Gasnier; B Giros
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 2.  Molecular physiology and pathophysiology of lysosomal membrane transporters.

Authors:  C Sagné; B Gasnier
Journal:  J Inherit Metab Dis       Date:  2008-04-15       Impact factor: 4.982

Review 3.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

4.  An extended proteome map of the lysosomal membrane reveals novel potential transporters.

Authors:  Agnès Chapel; Sylvie Kieffer-Jaquinod; Corinne Sagné; Quentin Verdon; Corinne Ivaldi; Mourad Mellal; Jaqueline Thirion; Michel Jadot; Christophe Bruley; Jérôme Garin; Bruno Gasnier; Agnès Journet
Journal:  Mol Cell Proteomics       Date:  2013-02-24       Impact factor: 5.911

5.  Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter.

Authors:  V Kalatzis; S Cherqui; C Antignac; B Gasnier
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

6.  Autophagy, mitochondria and cell death in lysosomal storage diseases.

Authors:  Kirill Kiselyov; John J Jennigs; Youssef Rbaibi; Charleen T Chu
Journal:  Autophagy       Date:  2007-05-23       Impact factor: 16.016

Review 7.  New aspects of the pathogenesis of cystinosis.

Authors:  Vasiliki Kalatzis; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2003-02-27       Impact factor: 3.714

Review 8.  The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases.

Authors:  James A Shayman; Scott D Larsen
Journal:  J Lipid Res       Date:  2014-02-17       Impact factor: 5.922

Review 9.  Mitochondrial Ca2+ homeostasis in lysosomal storage diseases.

Authors:  Kirill Kiselyov; Shmuel Muallem
Journal:  Cell Calcium       Date:  2008-02-01       Impact factor: 6.817

10.  Killing of intraerythrocytic Plasmodium falciparum by lysosomotropic amino acid esters.

Authors:  Miriam Krugliak; Jianmin Zhang; Edna Nissani; Sonia Steiner-Mordoch; Hagai Ginsburg
Journal:  Parasitol Res       Date:  2003-01-08       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.